Comparison of the Effects of Two Frequencies of Application of Photobiomodulation on Facial Rejuvenation
NCT ID: NCT04911140
Last Updated: 2024-09-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
95 participants
INTERVENTIONAL
2021-05-30
2023-12-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Application LED Therapy and Laser Therapy in Facial Rejuvenation
NCT02513680
Association of Photobiomodulation With Platelet Rich Plasma Intradermal Injection for Facial Rejuvenation
NCT04145999
Use of Red Light Emitting Diode (LED) and Polydioxanone Thread in Glabellar Wrinkles
NCT05720000
TCA Peel and Photobiomodulation for Hand Rejuvenation
NCT04485091
Skin Safety Profile of Different Exposure to the Light Emitting Diode (LED) in Healthy Subjects
NCT00818311
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Photobiomodulation twice a week
This group will receive the application of photobiomodulation (PBM) twice a week for 4 weeks.
Photobiomodulation twice a week
The photobiomodulation will be applied with a LED facial mask, Cosmedical brand (São Paulo, Brazil), containing 92 red LEDs, 660 nm of wavelength, in continuous mode for 21 minutes, twice a week, for 4 weeks.
Photobiomodulation three times a week
This group will receive the application of photobiomodulation (PBM) three times a week for 4 weeks.
Photobiomodulation three times a week
The photobiomodulation will be applied with a LED facial mask, Cosmedical brand (São Paulo, Brazil), containing 92 red LEDs, 660 nm of wavelength, in continuous mode for 21 minutes, three times a week, for 4 weeks.
Simulated Photobiomodulation
This group will receive the application of simulated photobiomodulation (PBM) twice a week for 4 weeks.
Simulated Photobiomodulation
Photobiomodulation will be simulated, with the device turned off, twice a week, for 4 weeks. The characteristic sound of the device will be triggered by recording.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Photobiomodulation twice a week
The photobiomodulation will be applied with a LED facial mask, Cosmedical brand (São Paulo, Brazil), containing 92 red LEDs, 660 nm of wavelength, in continuous mode for 21 minutes, twice a week, for 4 weeks.
Photobiomodulation three times a week
The photobiomodulation will be applied with a LED facial mask, Cosmedical brand (São Paulo, Brazil), containing 92 red LEDs, 660 nm of wavelength, in continuous mode for 21 minutes, three times a week, for 4 weeks.
Simulated Photobiomodulation
Photobiomodulation will be simulated, with the device turned off, twice a week, for 4 weeks. The characteristic sound of the device will be triggered by recording.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* At menopause (at least 12 months without menstruation);
* Healthy;
* Skin phototype I to IV by Fitzpatrick classification;
* Visible signs of skin aging grades III and IV of the Glogau scale.
Exclusion Criteria
* Who have any type of lesion on the skin of the face.
* Who use corticosteroids, anticoagulants, or any drug known to increase photosensitivity, including systemic retinoids and use of topical retinoic acid in the last 6 months.
* People with any collagen-related diseases, malnutrition, anemia, immunosuppression, cancer diseases, smokers, predisposition to hypertrophic and keloid scarring, history of dermatological diseases, surgery on the face, trauma to the face, diseases that could affect the condition of the skin and disease psychiatric.
* Who are in the menstrual period, in the climacteric or in hormone replacement therapy.
* Who underwent cosmetic procedures on the face, such as application of botulinum toxin in the last 8 months, facial filling in the last year, chemical peels, ablative laser and dermabrasion in the last 6 months.
* Who do not respect the post treatment recommendations or who fail to attend a treatment session.
* Those that, during the procedures, present any type of complication (hypersensitivity, allergies) will not be part of the statistical analysis, as these cases will not be in the expected pattern for these procedures. However, these data will be described and discussed, as well as the possible adverse effects and the participants will receive treatment to resolve the condition
45 Years
60 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Nove de Julho
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sandra Kalil Bussadori
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nove de Julho University
São Paulo, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Bragato EF, Paisano AF, Pavani C, Motta LJ, Varellis MLZ, Chiedde M, da Silva GA, Bussadori SK, Mesquita-Ferrari RA, Fernandes KPS. Role of photobiomodulation application frequency in facial rejuvenation: randomized, sham-controlled, double-blind, clinical trial. Lasers Med Sci. 2025 Apr 1;40(1):170. doi: 10.1007/s10103-025-04383-1.
Bragato EF, Pires JA, Momolli M, Guerra MB, Paisano AF, Ferrari RAM, Bussadori SK, Motta LJ, Fernandes KPS. Comparison of the effects of 2 frequencies of application of photobiomodulation on facial rejuvenation: Controlled, randomized, and double-blind clinical trial. Medicine (Baltimore). 2023 Feb 3;102(5):e32514. doi: 10.1097/MD.0000000000032514.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FacialRej
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.